Mamawala MK - Search Results

1

Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate-risk to very-high-risk clinically localised prostate cancer.

Gupta N, Bivalacqua TJ, Han M, Gorin MA, Challacombe BJ, Partin AW, Mamawala MK. Gupta N, et al. Among authors: mamawala mk. BJU Int. 2019 Aug;124(2):268-274. doi: 10.1111/bju.14659. Epub 2019 Jan 27. BJU Int. 2019. PMID: 30570825

2

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.

Tosoian JJ, Mamawala M, Epstein JI, Landis P, Wolf S, Trock BJ, Carter HB. Tosoian JJ, et al. J Clin Oncol. 2015 Oct 20;33(30):3379-85. doi: 10.1200/JCO.2015.62.5764. Epub 2015 Aug 31. J Clin Oncol. 2015. PMID: 26324359 Free PMC article.

3

Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery.

Tosoian JJ, Sundi D, Trock BJ, Landis P, Epstein JI, Schaeffer EM, Carter HB, Mamawala M. Tosoian JJ, et al. Eur Urol. 2016 Apr;69(4):576-581. doi: 10.1016/j.eururo.2015.09.032. Epub 2015 Oct 9. Eur Urol. 2016. PMID: 26456680

4

The Role of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Active Surveillance.

Ma TM, Tosoian JJ, Schaeffer EM, Landis P, Wolf S, Macura KJ, Epstein JI, Mamawala M, Carter HB. Ma TM, et al. Eur Urol. 2017 Feb;71(2):174-180. doi: 10.1016/j.eururo.2016.05.021. Epub 2016 May 25. Eur Urol. 2017. PMID: 27236496

5

Reply to Weigang Yan, Zhien Zhou, Hanzhong Li's Letter to the Editor re: Jeffrey J. Tosoian, Debasish Sundi, Bruce J. Trock, et al. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Eur Urol 2016;69:576-81.

Tosoian JJ, Trock BJ, Ballentine Carter H, Mamawala M. Tosoian JJ, et al. Eur Urol. 2017 Jan;71(1):e13. doi: 10.1016/j.eururo.2016.05.037. Epub 2016 Jun 13. Eur Urol. 2017. PMID: 27311363 No abstract available.

6

Prediction of the Pathologic Gleason Score to Inform a Personalized Management Program for Prostate Cancer.

Coley RY, Zeger SL, Mamawala M, Pienta KJ, Carter HB. Coley RY, et al. Eur Urol. 2017 Jul;72(1):135-141. doi: 10.1016/j.eururo.2016.08.005. Epub 2016 Aug 11. Eur Urol. 2017. PMID: 27523594

7

Prostate Health Index density improves detection of clinically significant prostate cancer.

Tosoian JJ, Druskin SC, Andreas D, Mullane P, Chappidi M, Joo S, Ghabili K, Mamawala M, Agostino J, Carter HB, Partin AW, Sokoll LJ, Ross AE. Tosoian JJ, et al. BJU Int. 2017 Dec;120(6):793-798. doi: 10.1111/bju.13762. Epub 2017 Feb 6. BJU Int. 2017. PMID: 28058757

8

Comparison of Biochemical Recurrence-Free Survival after Radical Prostatectomy Triggered by Grade Reclassification during Active Surveillance and in Men Newly Diagnosed with Similar Grade Disease.

Diniz CP, Landis P, Carter HB, Epstein JI, Mamawala M. Diniz CP, et al. J Urol. 2017 Sep;198(3):608-613. doi: 10.1016/j.juro.2017.03.122. Epub 2017 Mar 24. J Urol. 2017. PMID: 28347771

9

Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance.

Tosoian JJ, Mamawala M, Patel HD, Alam R, Epstein JI, Ross AE, Carter HB. Tosoian JJ, et al. J Urol. 2018 Apr;199(4):954-960. doi: 10.1016/j.juro.2017.10.029. Epub 2017 Oct 24. J Urol. 2018. PMID: 29074222

10

PTEN status assessment in the Johns Hopkins active surveillance cohort.

Tosoian JJ, Guedes LB, Morais CL, Mamawala M, Ross AE, De Marzo AM, Trock BJ, Han M, Carter HB, Lotan TL. Tosoian JJ, et al. Prostate Cancer Prostatic Dis. 2019 Mar;22(1):176-181. doi: 10.1038/s41391-018-0093-2. Epub 2018 Oct 2. Prostate Cancer Prostatic Dis. 2019. PMID: 30279579 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page